Lexaria Bioscience Corp. - COM NEW (LEXX)

Historical Holders from Q1 2021 to Q4 2025

Type / Class
Equity / COM NEW
Symbol
LEXX on Nasdaq
Price per share
$1.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,717,317
Total reported value
$1,634,673
% of total 13F portfolios
0%
Share change
-580,133
Value change
-$453,765
Number of holders
25
Price from insider filings
$1.06
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, Lexaria Bioscience Corp. - COM NEW (LEXX) has 25 institutional shareholders filing 13F forms. They hold 1,717,317 shares. .

Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 0 $0 -$29,934 $1.06 0
2025 Q3 1,717,317 $1,634,673 -$453,765 $0.95 25
2025 Q2 2,297,450 $1,999,388 +$851,079 $0.87 21
2025 Q1 1,239,756 $2,119,588 -$537,170 $1.71 22
2024 Q4 1,441,461 $3,026,861 +$641,163 $2.10 25
2024 Q3 1,066,674 $3,252,819 -$2,740,930 $3.05 27
2024 Q2 2,057,835 $5,720,708 +$3,236,557 $2.78 28
2024 Q1 888,794 $3,225,972 -$347,925 $3.63 25
2023 Q4 1,195,589 $1,494,550 -$493,306 $1.25 19
2023 Q3 1,771,138 $1,770,635 +$883,097 $1.00 14
2023 Q2 892,281 $651,351 +$101,928 $0.73 12
2023 Q1 678,680 $1,846,092 -$42,025 $2.72 15
2022 Q4 695,981 $1,709,524 +$22,671 $2.46 15
2022 Q3 686,764 $1,681,000 +$290,061 $2.45 14
2022 Q2 561,124 $1,671,000 +$261,493 $2.98 15
2022 Q1 472,493 $1,410,000 +$54,741 $3.29 11
2021 Q4 456,920 $1,849,000 -$8,044 $4.04 10
2021 Q3 451,867 $2,828,000 +$205,881 $6.26 9
2021 Q2 416,999 $2,923,000 +$713,924 $7.00 8
2021 Q1 317,785 $1,783,000 +$1,783,000 $5.61 7